Ctrl K
Last 19 quarters of trend data · Healthcare · Medical - Healthcare Information Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -11.43 | — | — | — | — | 1.84 | — | — | — | — | — | — | — | — | — | — | 40.35 | 16.97 | — | 29.08 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 28.74 | 35.32 | 122.46 | 13.75 | 59.13 | 35.31 | 33.61 | 365.99 | 30.00 | 25.90 | 16.95 | 9.14 | 241.67 | 440.44 | 268.05 | 34.90 | 136.96 | 162.73 | 94.75 | 190.70 |
| — | +0.0% | +264.4% | -96.2% | +97.1% | +36.3% | +98.3% | +3903.3% | -87.6% | -94.1% | -93.7% | -73.8% | +76.5% | +170.7% | +182.9% | -81.7% | — | — | — | — | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | 15.35 | — | 8.07 | 1.37 | 1.37 | — | 1.38 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +1017.8% | — | +485.9% | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | 0.24 | — | — | — | — | — | — | — | 105.39 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | 1.85 | — | — | — | — | — | — | — | — | — | — | 40.35 | 17.32 | — | 28.97 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -37.0% | -193.5% | -395.8% | 18.5% | -125.4% | -155.5% | -163.5% | -200.0% | -59.2% | -44.9% | -27.8% | 1.0% | 10.1% | -32.9% | -44.5% | 64.7% | -31.8% | -12.6% | 8.0% | -42.3% |
| — | -24.4% | -142.1% | +109.3% | -112.0% | -246.0% | -487.7% | -20236.9% | -684.4% | -36.4% | +37.5% | -98.5% | +131.8% | -161.4% | -657.8% | +252.8% | — | — | — | — | |
| Operating Margin | -711.3% | -774.3% | -2658.3% | -345.9% | -1262.7% | -1331.0% | -1623.4% | -10253.8% | -1681.0% | -1081.1% | -847.2% | -1163.0% | -591.1% | -908.1% | -734.5% | -367.5% | -283.8% | -99999900.0% | -104.2% | -50.1% |
| — | +41.8% | -63.8% | +96.6% | +24.9% | -23.1% | -91.6% | -781.6% | -184.4% | -19.0% | -15.3% | -216.5% | -108.3% | +100.0% | -605.0% | -633.8% | — | — | — | — | |
| Net Margin | -206.1% | -743.8% | -2555.2% | -352.4% | -418.6% | 1923.9% | -1388.3% | -9130.8% | -1449.3% | -1581.1% | -850.4% | -5355.5% | -4245.4% | -5549.7% | -3913.0% | -829.2% | 339.4% | 99999900.0% | -116.5% | 656.0% |
| — | -138.7% | -84.1% | +96.1% | +71.1% | +221.7% | -63.3% | -70.5% | +65.9% | +71.5% | +78.3% | -545.9% | -1351.0% | -100.0% | -3258.7% | -226.4% | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | -541.2% | -242.3% | -195.3% | -14.5% | 0.9% | 9509484.3% | -0.9% | 1.2% |
| — | — | — | — | — | — | — | — | — | — | — | — | -63551.2% | -100.0% | -21644.0% | -1324.7% | — | — | — | — | |
| ROA | -95.3% | -151.3% | -134.1% | -171.7% | -38.6% | 146.6% | -69.7% | -58.5% | -75.8% | -400.8% | -347.7% | -1073.1% | -84.1% | -60.8% | -51.1% | -12.9% | 0.8% | 8444441.3% | -0.8% | 1.1% |
| — | -203.2% | -92.5% | -193.5% | +49.1% | +136.6% | +80.0% | +94.5% | +9.8% | -558.8% | -580.7% | -8192.5% | -10555.4% | -100.0% | -6436.1% | -1280.8% | — | — | — | — | |
| ROIC | — | — | — | — | — | — | — | — | — | — | — | — | -12.7% | -10.5% | -11.6% | -4.8% | -0.5% | -837998.3% | -0.6% | — |
| — | — | — | — | — | — | — | — | — | — | — | — | -2271.2% | +100.0% | -1899.4% | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.18 | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.43 | 0.28 | 0.27 | 0.43 | 0.29 | 0.37 | 0.09 | 0.19 | 0.23 | 0.05 | 0.04 | 0.03 | 0.20 | 0.00 | 0.14 | 0.02 | 0.01 | 0.36 | 0.18 | 42.01 |
| — | -24.5% | +203.5% | +130.7% | +25.0% | +671.8% | +100.7% | +563.2% | +15.9% | +2800.9% | -66.9% | +81.7% | +3006.7% | -99.5% | -22.9% | -100.0% | — | — | — | — | |
| Quick Ratio | 0.43 | 0.28 | 0.27 | 0.43 | 0.29 | 0.37 | 0.09 | 0.19 | 0.23 | 0.05 | 0.04 | 0.03 | 0.20 | 0.00 | 0.14 | 0.02 | 0.01 | 0.36 | 0.18 | 42.01 |
| — | -24.5% | +203.5% | +130.7% | +25.0% | +671.8% | +100.7% | +563.2% | +15.9% | +2800.9% | -66.9% | +81.7% | +3006.7% | -99.5% | -22.9% | -100.0% | — | — | — | — | |
| Interest Coverage | -40.79 | -251.22 | -244.30 | -391.38 | -122.50 | 136.55 | -60.35 | -86.85 | -56.17 | -86.54 | -49.21 | -73.15 | -74.03 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 19 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ONMD stock.
OneMedNet Corporation's current P/E is -11.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
OneMedNet Corporation's current operating margin is -711.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking OneMedNet Corporation's business trajectory between earnings reports.